Research News

Crack GPAT — Prepare for GPAT Online 
  • Dual-Drug Breakthrough : A new pathway to treat Liver Fibrosis
    7 January 2026

    Dual-Drug Breakthrough: A new pathway to treat Liver Fibrosis

    Researchers have identified a promising new treatment strategy for liver fibrosis, a chronic condition that can lead to cirrhosis and liver cancer, by combining two well-known drugs. Preliminary findings suggest that using silybin together with carvedilol produces a powerful synergistic effect significantly stronger than either drug alone, against the cellular processes that drive scar tissue formation in the liver.
  • 7 January 2026
    Infant gut molecules offer clues to type 1 Diabetes risk
    In a groundbreaking study, scientists have uncovered a new class of gut-derived molecules in infancy that could reshape how researchers understand the development of type 1 diabetes. The international research team, led by experts at the University of Turku and Örebro University, investigated stool samples from more than 300 children between the ages of 3 and 36 months, all of whom had a genetic predisposition for type 1 diabetes.
  • 3 January 2026
    Breakthrough study finds traditional Medicinal Fungus shows strong antidiabetic potential

    A new peer-reviewed study has revealed that Sanghuangporus quercicola, a medicinal fungus long used in traditional practices across Asia, produces significantly varied secondary metabolites under different cultivation conditions, with notable in vitro antidiabetic activity emerging from the analyses.

  • 1 January 2026
    Enveric Biosciences Secures Key U.S. Patent to Broaden Neuropsychiatric Drug Pipeline
    Enveric Biosciences, a biotechnology company developing next-generation small-molecule neuroplastogenic therapeutics, announced the issuance of a significant new U.S. patent that enhances its intellectual property portfolio and expands opportunities for advancing treatments in mental health disorders.
  • 31 December 2025
    New Research Identifies Dihydrotanshinone I as a Potential Therapeutic Agent for Ovarian Cancer by Targeting SORT1

    A recent study published in Engineering has shed light on the potential therapeutic effects of dihydrotanshinone I (DHT), a compound derived from the traditional Chinese herb Salvia miltiorrhiza, on ovarian cancer. The research, conducted by a team from Zhejiang Chinese Medical University and Jiangsu Normal University, reveals that DHT can induce autophagic cell death in ovarian cancer cells by disrupting the sortilin 1 (SORT1)-mediated autophagy–lysosome pathway.

  • 26 December 2025
    New Global Study Questions Tramadol Use for Long-Term Pain Relief
    A new large systematic review published this week has raised important questions about the safety and effectiveness of tramadol, a widely prescribed opioid for chronic pain relief. The study, published online ahead of print in BMJ Evidence-Based Medicine, finds that while tramadol does reduce pain compared with placebo, the benefit is small and may not be clinically meaningful for many patients.
  • 26 December 2025
    New Hope for Thalassemia Patients as FDA Greenlights Agios’ Aqvesme – But Cautions Remain
    A major breakthrough for adults living with rare inherited blood disorders, the U.S. Food and Drug Administration (FDA) has officially approved Agios Pharmaceuticals’ oral drug AQVESME™ (mitapivat) for the treatment of anemia in both alpha- and beta-thalassemia, regardless of whether patients require regular blood transfusions or not.
  • 26 December 2025
    Biofabri–Bharat Biotech pact brings fresh hope in global fight against Tuberculosis
    Biofabri and Bharat Biotech International Limited have signed a technology transfer agreement aimed at improving worldwide access to the promising TB vaccine candidate, MTBVAC.
  • 24 December 2025
    New WHO Report Shows Big Gaps in Global Genomics Research
    The World Health Organization (WHO) has come out with a new global analysis that shows there are major equity gaps in human genomics research, especially between rich and poorer countries.
  • 18 December 2025
    New antimalarial drug candidate shows potential for fighting resistance and reducing malaria transmission

    Researchers have developed a new antimalarial drug candidate designed to address the growing challenge of drug resistance and potentially reduce malaria transmission.

Subscribe to Research News